Smokers have a two- or three-times higher chance of developing cataracts and up to four times higher risk for AMD. Future ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.

Moderate to severe obstructive sleep apnea was associated with significantly higher odds of having neovascular age-related macular degeneration, according to a study published in Clinical & ...

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

The FDA has expanded the labeling for Izervay (avacincaptad pegol) to include longer-term administration for geographic ...

IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

More than 20% of Hawai‘i residents are over the age of 65 years old, possibly making them more at risk for eye diseases, health officials report. One such disease to be aware of is age-related macular ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Can supplementing with vitamins and minerals protect your eye health? Learn more about the role of nutrients in age-related ...

D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.